{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-001228","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.921549+00:00","generated_at":"2026-05-28T03:15:39.101442+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Avalo Therapeutics posts updated investor presentation; no specific financial details disclosed","bullets":["Avalo posted an updated corporate presentation on its website on Jan 13, 2025.","The filing does not disclose any specific financial, pipeline, or strategic updates from the presentation.","No new earnings, guidance, or material events were announced in connection with the posting.","The only document attached is the presentation cover slide; investors must access the full deck for details."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-001228","json":"https://secwatch.observer/filing/0001628280-25-001228.json","markdown":"https://secwatch.observer/filing/0001628280-25-001228.md","text":"https://secwatch.observer/filing/0001628280-25-001228.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000162828025001228/0001628280-25-001228-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000162828025001228/avtx-20250113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:15:39.101442+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}